Biofer

Biofer is an Italian pharmaceutical company that specializes in the research, development, and manufacturing of active pharmaceutical ingredients (APIs), with a core focus on iron-carbohydrate complexes for the treatment of anemia. The company is a global leader in the production of complex iron salts, such as Iron Sucrose and Iron Hydroxide Polymaltose, which are used in intravenous and oral therapies for iron deficiency. Headquartered in Medolla, Italy, Biofer operates high-standard GMP manufacturing facilities and provides both proprietary products and CDMO services to international pharmaceutical partners. In 2024, the company was acquired by the Greek pharmaceutical group RAFARM, integrating its specialized iron-based technology into a broader global portfolio.